Western Blot: 2-4 μg/mL. Immunohistochemistry: 20 μg/mL. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Concentration
0.5 mg/mL
Buffer
PBS, 0.02 % Thimerosal, 50 % Glycerol, 1 % BSA
Agent conservateur
Thimerosal (Merthiolate)
Précaution d'utilisation
This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C/-80 °C
Stockage commentaire
Store the antibody undiluted at -20 °C or for long term storage (in aliquots) at -70 °C. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
Date de péremption
12 months
Antigène
SERPINB9
(serpin Peptidase Inhibitor, Clade B (Ovalbumin), Member 9 (SERPINB9))
anticorps SERPINB9, anticorps BB283241, anticorps CAP-3, anticorps CAP3, anticorps PI-9, anticorps PI9, anticorps Spi6, anticorps ovalbumin, anticorps serpin family B member 9, anticorps serpin peptidase inhibitor, clade B (ovalbumin), member 9, anticorps serine (or cysteine) peptidase inhibitor, clade B, member 9, anticorps Serpinb9, anticorps SERPINB9
Sujet
Proteinase inhibitor 9 (PI-9, also designated cytoplasmic antiproteinase 3, or CAP3) is a 42 kDa member of the ovalbumin family of serpins that is expressed in placenta, lung and cytotoxic lymphocytes. PI-9 is a potent inhibitor of granzyme B and of granzyme B-mediated apoptosis, and is also an inhibitor of capase-1 and, to a smaller extent, caspase-4 and caspase-8. PI-9 expression is also upregulated in response to inflammatory stimuli. This upregulation protects cells from apoptosis induced by endogenously expressed or released granzyme B, particulary during target cell killling.Synonyms: CAP-3, CAP3, Cytoplasmic antiproteinase 3, PI-9, PI9, Proteinase inhibitor 9, Serpin B9